|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - EAGLE PHARMACEUTICALS Inc (EGRX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-10-07 Sale |
2019-10-09 4:13 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director |
6,459 | $60.09 | $388,119 | 805,464 (Indirect) |
View |
| 2019-09-17 Sale |
2019-09-19 4:13 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director |
100 | $60 | $6,000 | 810,365 (Indirect) |
View |
| 2019-09-11 Sale |
2019-09-13 4:43 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Hudson Executive Capital LP HEC Management GP LLC Braunstein Douglas L Director |
1,312 | $60.06 | $78,799 | 810,665 (Indirect) |
View |
| 2019-05-09 Sale |
2019-05-13 5:52 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director |
159,223 | $56.81 | $9,045,973 | 911,777 (Indirect) |
View |
| 2019-03-01 Sale |
2019-03-04 4:31 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
24,428 | $51.17 | $1,250,015 | 1,537,605 (Direct) |
View |
| 2019-02-01 Sale |
2019-02-04 8:04 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
30,085 | $41.54 | $1,249,831 | 1,550,505 (Direct) |
View |
| 2019-01-02 Sale |
2019-01-04 9:22 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
31,569 | $39.49 | $1,246,763 | 1,543,459 (Direct) |
View |
| 2018-03-05 Sale |
2018-03-07 4:16 pm |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
2,340 | $53.94 | $126,220 | 13,714 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-10-08 Option Award |
2019-10-10 08:02 am |
N/A 2029-10-08 |
EAGLE PHARMACEUTICALS Inc | EGRX | Simpson Jennifer K. Director |
10,000 | $58.88 | 10,000 (Direct) |
View |
| 2019-04-01 Sale |
2019-04-03 4:33 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
24,975 | $50.15 | 1,500,202 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 4:42 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
2,340 | $4.04 | 18,004 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-06 4:42 pm |
N/A 2019-03-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
2,340 | $4.04 | 18,004 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-06 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
2,340 | $4.04 | 13,714 (Direct) |
View |
| 2019-03-05 Tax Withholding |
2019-03-06 4:41 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
204 | $48.89 | 13,714 (Direct) |
View |
| 2019-03-05 Exercise |
2019-03-06 4:41 pm |
N/A 2019-03-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
2,340 | $4.04 | 13,714 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 9:24 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:07 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
61,300 | $0 | 1,579,690 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:07 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO, 10% Owner |
137,200 | $42.4 | 1,579,690 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:06 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-25 8:05 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
858 | $41.33 | 46,600 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:05 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
20,900 | $0 | 46,600 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:05 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
46,600 | $42.4 | 46,600 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-25 8:04 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
600 | $41.33 | 43,200 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:04 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
19,300 | $0 | 43,200 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:04 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
43,200 | $42.4 | 43,200 (Direct) |
View |
| 2019-01-07 Tax Withholding |
2019-01-25 8:04 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
771 | $41.33 | 42,500 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:04 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
19,000 | $0 | 42,500 (Direct) |
View |
| 2019-01-07 Option Award |
2019-01-25 8:04 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
42,500 | $42.4 | 42,500 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:03 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Graves Michael Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:02 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Glenning Robert Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 8:01 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2019-01-23 Option Award |
2019-01-25 7:58 pm |
N/A 2029-01-23 |
EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director |
10,000 | $42.4 | 10,000 (Direct) |
View |
| 2018-06-28 Exercise |
2018-07-03 5:09 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
124,804 | $4.04 | 1,549,959 (Direct) |
View |
| 2018-06-28 Exercise |
2018-07-03 5:09 pm |
N/A 2019-04-02 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
124,804 | $4.04 | 1,549,959 (Direct) |
View |
| 2018-03-30 Exercise |
2018-04-03 5:05 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
113,104 | $4.04 | 1,483,050 (Direct) |
View |
| 2018-03-30 Tax Withholding |
2018-04-03 5:05 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
57,895 | $52.69 | 1,483,050 (Direct) |
View |
| 2018-03-30 Exercise |
2018-04-03 5:05 pm |
N/A 2018-10-02 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
113,104 | $4.04 | 1,483,050 (Direct) |
View |
| 2018-03-05 Exercise |
2018-03-07 4:16 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
2,340 | $0.9 | 13,714 (Direct) |
View |
| 2018-03-05 Exercise |
2018-03-07 4:16 pm |
N/A 2018-03-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
2,340 | $0.9 | 13,714 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:50 pm |
N/A 2028-01-07 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
157,000 | $59.14 | 189,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:50 pm |
N/A 2021-01-01 |
EAGLE PHARMACEUTICALS Inc | EGRX | Tarriff Scott CEO |
189,000 | $0 | 189,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:49 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:48 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
10,000 | $0 | 50,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:48 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
50,000 | $59.14 | 50,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:48 pm |
N/A 2021-01-01 |
EAGLE PHARMACEUTICALS Inc | EGRX | Pernock David Pres. & Chief Comm. Officer |
30,000 | $0 | 50,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:46 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
7,000 | $0 | 37,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:46 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
37,000 | $59.14 | 37,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:46 pm |
N/A 2021-01-01 |
EAGLE PHARMACEUTICALS Inc | EGRX | Meyers Pete A. CFO |
21,000 | $0 | 37,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:45 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
3,000 | $0 | 15,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:45 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
15,000 | $59.14 | 15,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:45 pm |
N/A 2021-01-01 |
EAGLE PHARMACEUTICALS Inc | EGRX | Krill Steven L. EVP & Chief Scientific Officer |
9,000 | $0 | 15,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:44 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
9,000 | $0 | 43,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:44 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
43,000 | $59.14 | 43,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:44 pm |
N/A 2021-01-01 |
EAGLE PHARMACEUTICALS Inc | EGRX | Hepner Adrian EVP and Chief Medical Officer |
27,000 | $0 | 43,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:42 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Graves Michael Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:41 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Glenning Robert Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:39 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | FLAUM SANDER A Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:38 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Edlin Richard A. Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2018-01-07 Option Award |
2018-01-09 5:36 pm |
N/A 2028-01-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | Braunstein Douglas L Director |
10,000 | $59.14 | 10,000 (Direct) |
View |
| 2017-12-18 Exercise |
2017-12-20 5:54 pm |
N/A N/A |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
2,340 | $0.9 | 15,664 (Direct) |
View |
| 2017-12-18 Exercise |
2017-12-20 5:54 pm |
N/A 2018-03-06 |
EAGLE PHARMACEUTICALS Inc | EGRX | RATOFF STEVEN B Director |
2,340 | $0.9 | 15,664 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 14 Oct 2019 08:13:17 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |